Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
11/06/2007 | CA2363713C Lantibiotic |
11/06/2007 | CA2356310C External preparations containing a basic drug |
11/06/2007 | CA2271388C Liposomes encapsulating polynucleotides operatively coding for immunogenic polypeptides |
11/06/2007 | CA2193129C Transdermal drug delivery system |
11/06/2007 | CA2114251C Igf-1 to improve the neural condition |
11/06/2007 | CA2010058C Storage of materials |
11/01/2007 | WO2007124465A2 Stable emulsion formulations |
11/01/2007 | WO2007124372A2 Pharmaceutical formulations for iontophoretic methotrexate delivery |
11/01/2007 | WO2007124358A2 Pharmaceutical formulations for iontophoretic drug delivery |
11/01/2007 | WO2007124250A2 Methods of treating hot flashes with formulations for transdermal or transmucosal application |
11/01/2007 | WO2007124224A2 Method for delivering particulate drugs to tissues |
11/01/2007 | WO2007124198A2 Biopolymer system for tissue sealing |
11/01/2007 | WO2007124164A2 Devices and methods of drying objects using aerosols |
11/01/2007 | WO2007123993A2 Niosome-hydrogel drug delivery |
11/01/2007 | WO2007123984A2 Pre-mixed, ready-to-use pharmaceutical compositions |
11/01/2007 | WO2007123955A2 Stable hydroalcoholic oral spray formulations and methods |
11/01/2007 | WO2007123883A2 Oral dosage formulations and methods of preparing the same |
11/01/2007 | WO2007123872A2 Polyesteramide platform for site specific drug delivery |
11/01/2007 | WO2007123867A2 Stable solutions of prostaglandin and uses of same |
11/01/2007 | WO2007123800A2 Stabilized pentosan polysulfate (pps) formulations and methods of analyzing them |
11/01/2007 | WO2007123793A2 Swellable particles for drug delivery |
11/01/2007 | WO2007123790A1 Nanostructured compositions having antibacterial, anti-fungal, anti-yeast, and/or anti-viral properties |
11/01/2007 | WO2007123789A2 Water resistant film forming compositions incorporating hydrophilic activities |
11/01/2007 | WO2007123740A2 Pharmaceutical compositions for promoting wound healing |
11/01/2007 | WO2007123691A2 Method for treating blood coagulation disorders |
11/01/2007 | WO2007123284A1 Alpha lipoic acid capsule composition stabilized in water phase and method for preparing the same |
11/01/2007 | WO2007123207A1 Fluid container and airless fluid dispensing system |
11/01/2007 | WO2007123193A1 Sprayable gel-type skin/mucosa-adhesive preparation and administration system using the preparation |
11/01/2007 | WO2007123153A1 Capsule for oral administration |
11/01/2007 | WO2007123044A1 Licorice polyphenol preparation |
11/01/2007 | WO2007123021A1 Method for producing extended release tablet |
11/01/2007 | WO2007122956A1 Titanium oxide complex particle, dispersion solution of the particle, and process for production of the particle |
11/01/2007 | WO2007122813A1 Solid preparation for oral application |
11/01/2007 | WO2007122756A1 Therapeutic agent for allergy containing liposome having oligosaccharide on its surface |
11/01/2007 | WO2007122624A2 Non-covalent complexes of bioactive agents with starch for oral delivery |
11/01/2007 | WO2007122510A2 Asymmetric membranes for drug delivery devices |
11/01/2007 | WO2007122478A2 Multiple unit compositions |
11/01/2007 | WO2007122374A2 Colonic drug delivery formulation |
11/01/2007 | WO2007122212A1 Oral rapid release pharmaceutical formulation for pyridylmethylsulfinyl-benzimidazoles |
11/01/2007 | WO2007122015A1 Tolterodine beads |
11/01/2007 | WO2007121949A1 Transdermal delivery system comprising sufentanil and its analogues |
11/01/2007 | WO2007121947A1 Lipoplex formulations for specific delivery to vascular endothelium |
11/01/2007 | WO2007121913A2 Pharmaceutical solution formulations for pressurised metered dose inhalers |
11/01/2007 | WO2007121867A1 Polymeric masticatory masses for cosmetic products |
11/01/2007 | WO2007121866A1 Chewing compositions for cosmetic products |
11/01/2007 | WO2007121848A1 Co-precipitate of chitin or chitin derivative and a silicon dioxide or derivative for the use as tablet excipient |
11/01/2007 | WO2007121807A1 Paediatric amino acid solution for parenteral nutrition |
11/01/2007 | WO2007121584A1 Food product containing policosanols |
11/01/2007 | WO2007121537A1 Controlled release formulations comprising uncoated discrete unit(s) and an extended release matrix |
11/01/2007 | WO2007121523A1 Pharmaceutical compositions of oxcarbazepine with a median particle size of 15 to 30 microns |
11/01/2007 | WO2007107305A3 Treatment of triple receptor negative breast cancer |
11/01/2007 | WO2007103200A9 Oral controlled release formulation for sedative and hypnotic agents |
11/01/2007 | WO2007103113A3 Dosage forms for administering combinations of drugs |
11/01/2007 | WO2007098945A3 Stable solid dosage form comprising desmopressin |
11/01/2007 | WO2007093897A3 Process of making herbal composition with masked bitter taste and product thereof |
11/01/2007 | WO2007092318A3 Spill resistant antibiotic formulations |
11/01/2007 | WO2007090987A3 Palatable support with an improved formula |
11/01/2007 | WO2007087557A3 Surface-layer protein coated microspheres and uses thereof |
11/01/2007 | WO2007084418A3 Microparticle containing matrices for drug delivery |
11/01/2007 | WO2007076117A3 Liposomal formulations comprising secondary and tertiary amines and methods for preparing thereof |
11/01/2007 | WO2007075680A3 System and method for delivering a desired material to a cell |
11/01/2007 | WO2007071012A8 Stabilized pharmaceutical compositions comprising an hmg-coa reductase inhibitor |
11/01/2007 | WO2007070852A3 Processes for making particle-based pharmaceutical formulations for parenteral administration |
11/01/2007 | WO2007070840A3 Modified and pulsatile release pharmaceutical formulations of escitalopram |
11/01/2007 | WO2007068963A3 Therapeutic compositions comprising ingenol-3-angelate |
11/01/2007 | WO2007059515A3 Compositions of lipoxygenase inhibitors |
11/01/2007 | WO2007050631A3 Dosage form with coated active |
11/01/2007 | WO2007030589A3 Pharmaceutical dosage forms and compositions comprising lecoztan |
11/01/2007 | WO2007028053A3 Methods of treating and preventing cardiac disorders |
11/01/2007 | WO2007017436A3 Method for the protection against the risk of cardiac disorders comprising administration of tiotropium salts |
11/01/2007 | WO2006099078A3 High flux, microporous, sieving membranes and separators containing such membranes and processes using such membranes |
11/01/2007 | US20070255262 Infusion device with positive pressure elastic bladder reservoir |
11/01/2007 | US20070255261 Infusion device with active and passive check valves |
11/01/2007 | US20070255260 Infusion device and pressure-based overfill protection mechanism for use with same |
11/01/2007 | US20070255233 Implantable therapeutic substance delivery system with catheter access port control and method of use |
11/01/2007 | US20070255205 Molded Micro-Needles |
11/01/2007 | US20070255197 Method of Treatment for Undesired Effect Following Transdermal or Topical Drug Delivery |
11/01/2007 | US20070255117 Enhanced ultrasound detection with temperature-dependent contrast agents |
11/01/2007 | US20070254953 Topical compositions of urea and ammonium lactate |
11/01/2007 | US20070254851 Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
11/01/2007 | US20070254053 lowering blood sugar by administering extracts of Costus pictus to mammals having hyperglycemia |
11/01/2007 | US20070254039 High loadings of an absorbent, calcium magnesium silicate, to neutralize odors/sebum in cosmetic and/or personal careformulations; hydrophobic, erodable polymer coatings for stability and viscosity concerns allow for coexistence with low pH materials; antiprespirants |
11/01/2007 | US20070254038 Microspheroidal Controlled Release Of Biomolecules |
11/01/2007 | US20070254037 Methods and Compositions for the Treatment of Cell Proliferation |
11/01/2007 | US20070254036 Treatment of menopause associated symptoms |
11/01/2007 | US20070254035 Preparing Active Polymer Extrudates |
11/01/2007 | US20070254034 Activated Foam |
11/01/2007 | US20070254033 Modified-release preparations containing oxcarbazepine and derivatives thereof |
11/01/2007 | US20070254032 Osmotic drug delivery system |
11/01/2007 | US20070254031 Rapidly disintegrable solid preparation |
11/01/2007 | US20070254030 Tablets; contains diuretic such as hydrochlorothiazide |
11/01/2007 | US20070254029 Method for ameliorating muscle weakness/wasting in a patient infected with human immunodeficiency virus-type 1 |
11/01/2007 | US20070254028 Granules Comprising a Nsaid and a Sugar Alcohol Made by Melt Extrusion |
11/01/2007 | US20070254026 Softgel capsules |
11/01/2007 | US20070254025 Oral contraceptive and acne medication combination and treatment of acne with reduced side effects |
11/01/2007 | US20070254024 Process for manufacturing films |
11/01/2007 | US20070254023 Perorally Administrable Antimicrobial Composition |
11/01/2007 | US20070254022 Cationic liposome delivery of taxanes to angiogenic blood vessels |
11/01/2007 | US20070254021 liposomes; prevents signs of aging, improves aesthetic appearance of skin, and promotes recovery from environmental stresses; extracts from rosemary, Centella, Echinacea, Alpinia |
11/01/2007 | US20070254020 Molecular communication system and molecular communication method |